Literature DB >> 12011117

Biochemotherapy for advanced melanoma: maybe it is real.

David Khayat, Chantal Bernard-Marty, Jean-Baptiste Meric, Olivier Rixe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12011117     DOI： 10.1200/JCO.2002.20.10.2411

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

Authors:  Takuji Mori; Steven J O'Day; Naoyuki Umetani; Steve R Martinez; Minoru Kitago; Kazuo Koyanagi; Christine Kuo; Teh-Ling Takeshima; Robert Milford; He-Jing Wang; Vu D Vu; Sandy L Nguyen; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

2.  Clinical features of malignant melanoma of the finger and therapeutic efficacies of different treatments.

Authors:  Zuozhang Yang; Lin Xie; Yunchao Huang; Hongpu Sun; Tao Yuan; Xiang Ma; Congguo Jing; Pengjie Liu
Journal:  Oncol Lett       Date:  2011-06-10       Impact factor: 2.967

3.  Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.

Authors:  Kazuo Koyanagi; Steven J O'Day; Rene Gonzalez; Karl Lewis; William A Robinson; Thomas T Amatruda; He-Jing Wang; Robert M Elashoff; Hiroya Takeuchi; Naoyuki Umetani; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

4.  Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.

Authors:  Kazuo Koyanagi; Takuji Mori; Steven J O'Day; Steve R Martinez; He-Jing Wang; Dave S B Hoon
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 5.  Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.

Authors:  Brigid S Mumford; Gavin P Robertson
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

6.  Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group.

Authors:  P Terheyden; A-K Kortüm; H-J Schulze; B Durani; R Remling; C Mauch; V Junghans; D Schadendorf; U Beiteke; M Jünger; J C Becker; E-B Bröcker
Journal:  J Cancer Res Clin Oncol       Date:  2007-03-03       Impact factor: 4.322

Review 7.  WITHDRAWN: Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.

Authors:  Andre D Sasse; Emma C Sasse; Luciana Go Clark; Otavio Augusto Camara Clark
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06

Review 8.  Cutaneous melanoma: new advances in treatment.

Authors:  Michele Ceolin Foletto; Sandra Elisa Haas
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

9.  Extracellular Vesicles Shedding Promotes Melanoma Growth in Response to Chemotherapy.

Authors:  Luciana Nogueira de Sousa Andrade; Andréia Hanada Otake; Silvia Guedes Braga Cardim; Felipe Ilelis da Silva; Mariana Mari Ikoma Sakamoto; Tatiane Katsue Furuya; Miyuki Uno; Fátima Solange Pasini; Roger Chammas
Journal:  Sci Rep       Date:  2019-10-09       Impact factor: 4.379

10.  Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death.

Authors:  Tharcisio Citrangulo Tortelli; Lyris Martins Franco de Godoy; Gustavo Antonio de Souza; Diego Bonatto; Andreia Hanada Otake; Renata de Freitas Saito; Jose Cesar Rosa; Lewis Joel Greene; Roger Chammas
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.